对接受生物治疗的牛皮患者进行探索性回顾性评估
Andrada-Luciana Lazar1,2, Sorana D Bolboacă3, Adrian-Lucian Baican4
14th Medical Clinic, Internal Medicine Department, "Iuliu Haţieganu" University of Medicine and Pharmacy Cluj-Napoca, 400347 Cluj-Napoca, Cluj, Romania.
Medicina (Kaunas, Lithuania)
|February 27, 2026
概括
生物疗法显著改善了罗马尼亚患者的牛皮结局. 像抗IL-17和抗IL-23这样的较新的药物显示出比抗TNF疗法更高的疗效,治疗切换的次数更少.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮是一种慢性炎症性皮肤疾病,影响疾病的严重程度和生活质量.
- 生物疗法提供了显著的好处,但关于罗马尼亚患者群体的数据很少.
- 了解罗马尼亚的生物治疗模式和结果对于优化患者护理至关重要.
研究的目的:
- 来自罗马尼亚特兰西瓦尼亚的牛皮病患者的特征.
- 评估生物疗法 (抗TNF,抗IL-17,抗IL-23) 对疾病严重性的影响.
- 评估治疗转换,生活质量 (DLQI) 和实验室生物标志物.
主要方法:
- 这是一项回顾性探索性研究,利用从罗马尼亚克卢日纳波卡的两个中心定期收集的医疗数据.
- 对115名用抗TNF,抗IL-17或抗IL-23生物药物治疗的患者进行评估.
- 分析患者人口统计,先前的治疗,并发症,疾病严重程度得分 (PASI) 和生活质量.
主要成果:
- 接受抗IL-17或抗IL-23治疗的患者在诊断时比接受抗TNF治疗的患者年龄更大 (p=0.0001).
- 头皮 (58.3%) 和指甲 (36.5%) 的参与是常见的;心脏代谢并发症是普遍存在的.
- 与抗TNF (p=0.045) 相比,抗IL-17/抗IL-23疗法在36周表现出更好的结果;由于有效性降低,抗TNF的切换率更高 (57.8%).
结论:
- 生物疗法显著改善了罗马尼亚患者的牛皮严重程度和生活质量.
- 与抗TNF药物相比,抗IL-17和抗IL-23生物药物表现出更好的疗效和更低的切换率.
- 不管病变的局部位置如何,使用生物药物观察到临床改善.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
658
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
658
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Nephrotic Syndrome II : Assessment and Medical Management
279
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
279


